I'm disappointed that there aren't more 2's going, but you can't blame people. .0002 is an amazing buy in price for what this company will be, however the fact is without revenue it's just too risky for some people to trust with the past and how other OTCs are. I have high hopes and will hold this for as long as it takes, but the feature of our investments lies in Chris coming through with what he's posted on Twitter. I would like to see a PR soon outlining things for the future as do most people. But I fear late March is the next time Emaji will PR.

Please prove me wrong on that Chris and good luck sir